Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody

NCT03282435 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

BIOLOGICAL: CIK cells with PD-1 blocking
OTHER: standard lung cancer treament
BIOLOGICAL: CIK cells without PD-1 blocking

Sponsor

Dalian University